273 related articles for article (PubMed ID: 25243137)
1. Newcastle disease virus interaction in targeted therapy against proliferation and invasion pathways of glioblastoma multiforme.
Abdullah JM; Mustafa Z; Ideris A
Biomed Res Int; 2014; 2014():386470. PubMed ID: 25243137
[TBL] [Abstract][Full Text] [Related]
2. Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion.
García-Romero N; Palacín-Aliana I; Esteban-Rubio S; Madurga R; Rius-Rocabert S; Carrión-Navarro J; Presa J; Cuadrado-Castano S; Sánchez-Gómez P; García-Sastre A; Nistal-Villan E; Ayuso-Sacido A
Cells; 2020 Jun; 9(6):. PubMed ID: 32516884
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL.
Kazimirsky G; Jiang W; Slavin S; Ziv-Av A; Brodie C
Stem Cell Res Ther; 2016 Oct; 7(1):149. PubMed ID: 27724977
[TBL] [Abstract][Full Text] [Related]
4. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
Li Q; Dong C; Cui J; Wang Y; Hong X
J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA‑376a inhibits cell proliferation and invasion in glioblastoma multiforme by directly targeting specificity protein 1.
Li Y; Wu Y; Sun Z; Wang R; Ma D
Mol Med Rep; 2018 Jan; 17(1):1583-1590. PubMed ID: 29257212
[TBL] [Abstract][Full Text] [Related]
6. MiR-1271 regulates glioblastoma cell proliferation and invasion by directly targeting the CAMKK2 gene.
Huang YK; Su YF; Lieu AS; Loh JK; Li CY; Wu CH; Kuo KL; Lin CL
Neurosci Lett; 2020 Oct; 737():135289. PubMed ID: 32791096
[TBL] [Abstract][Full Text] [Related]
7. αvβ8 integrin interacts with RhoGDI1 to regulate Rac1 and Cdc42 activation and drive glioblastoma cell invasion.
Reyes SB; Narayanan AS; Lee HS; Tchaicha JH; Aldape KD; Lang FF; Tolias KF; McCarty JH
Mol Biol Cell; 2013 Feb; 24(4):474-82. PubMed ID: 23283986
[TBL] [Abstract][Full Text] [Related]
8. Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme.
Freeman AI; Zakay-Rones Z; Gomori JM; Linetsky E; Rasooly L; Greenbaum E; Rozenman-Yair S; Panet A; Libson E; Irving CS; Galun E; Siegal T
Mol Ther; 2006 Jan; 13(1):221-8. PubMed ID: 16257582
[TBL] [Abstract][Full Text] [Related]
9. Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme.
Tilak M; Holborn J; New LA; Lalonde J; Jones N
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673213
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma multiforme: novel therapeutic targets.
Muir M; Gopakumar S; Traylor J; Lee S; Rao G
Expert Opin Ther Targets; 2020 Jul; 24(7):605-614. PubMed ID: 32394767
[TBL] [Abstract][Full Text] [Related]
11. Targeting role of glioma stem cells for glioblastoma multiforme.
Zhang X; Zhang W; Mao XG; Zhen HN; Cao WD; Hu SJ
Curr Med Chem; 2013; 20(15):1974-84. PubMed ID: 23317162
[TBL] [Abstract][Full Text] [Related]
12. CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme.
Daniele S; La Pietra V; Piccarducci R; Pietrobono D; Cavallini C; D'Amore VM; Cerofolini L; Giuntini S; Russomanno P; Puxeddu M; Nalli M; Pedrini M; Fragai M; Luchinat C; Novellino E; Taliani S; La Regina G; Silvestri R; Martini C; Marinelli L
Eur J Pharmacol; 2021 Apr; 897():173936. PubMed ID: 33581134
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.
Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y
Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Ultra-Microscopic Changes and Proliferation of Apoptotic Glioblastoma Multiforme Cells Induced by Velogenic Strain of Newcastle Disease Virus AF2240.
Ali- Saeed R; Alabsi AM; Ideris A; Omar AR; Yusoff K; Ali AM
Asian Pac J Cancer Prev; 2019 Mar; 20(3):757-765. PubMed ID: 30909682
[TBL] [Abstract][Full Text] [Related]
15. The oncolytic Newcastle disease virus as an effective immunotherapeutic strategy against glioblastoma.
Cuoco JA; Rogers CM; Mittal S
Neurosurg Focus; 2021 Feb; 50(2):E8. PubMed ID: 33524945
[TBL] [Abstract][Full Text] [Related]
16. Targeting strategies on miRNA-21 and PDCD4 for glioblastoma.
Wang G; Wang JJ; Tang HM; To SS
Arch Biochem Biophys; 2015 Aug; 580():64-74. PubMed ID: 26142886
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic pathways and glioblastoma treatment.
Clarke J; Penas C; Pastori C; Komotar RJ; Bregy A; Shah AH; Wahlestedt C; Ayad NG
Epigenetics; 2013 Aug; 8(8):785-95. PubMed ID: 23807265
[TBL] [Abstract][Full Text] [Related]
18. The role of Myc and let-7a in glioblastoma, glucose metabolism and response to therapy.
Wang G; Wang J; Zhao H; Wang J; Tony To SS
Arch Biochem Biophys; 2015 Aug; 580():84-92. PubMed ID: 26151775
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.
Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X
Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473
[TBL] [Abstract][Full Text] [Related]
20. Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.
Li M; Mukasa A; Inda MM; Zhang J; Chin L; Cavenee W; Furnari F
J Exp Med; 2011 Dec; 208(13):2657-73. PubMed ID: 22162832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
